Synthesis of compounds and intermediates
Closed Solicitation Posted
- Solicitation number
- 75N98026Q00970
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- 6810 Chemicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of the Director, seeks synthesis of five custom chemical compounds and intermediates to support Ewing sarcoma research, with responses due August 24, 2026 at 8:00 AM EST. This is a competitive, unrestricted acquisition under FAR 12.603 for commercial items, conducted with full and open competition on a firm-fixed-price basis.
Delivery is FOB Destination to NIH/NCATS, 9808 Medical Center Drive, Rockville, Maryland. The contractor shall synthesize and deliver 5 grams each of five target compounds—ABCL-0482, A1-133143, A1-133142, ABCL-0485, and A1-133147—under non-GMP conditions with a minimum purity of 95%, accompanied by a Certificate of Analysis for each compound. Performance begins upon purchase order receipt and continues for up to 12 weeks, with estimated lead times ranging from 8 to 12 weeks per compound. Deliverables include the synthesized compounds, Certificates of Analysis, biweekly written progress updates, and final shipment notification.
The NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), with a small business size standard of 1,000 employees. The acquisition is not expected to exceed the simplified acquisition threshold. Evaluation factors are price, technical capability, past performance, and delivery schedule. Quotations must include unit and total price, shipping and handling costs, delivery timeframe, delivery terms, F.O.B. point, and product description. All offerors must be registered in SAM with valid UEI and TIN. The contracting specialist is Jaddua Johnston, 240-569-0006, Jaddua.Johnston@nih.gov.
Notice text
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00970. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026
(iv) The associated NAICS code is 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and the small business size standard is 1000 employees.
This requirement is unrestricted.
Files
| File | Type | Posted |
|---|---|---|
| Sol_75N98026Q00970.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity